# Acadia Pharmaceuticals Inc: Form 8-K, filed Nov 3, 2025

- Company: [Acadia Pharmaceuticals Inc](/companies/acad.md) (CIK 1070494)
- Form: 8-K
- Filed: 2025-11-03
- Accepted by EDGAR: Nov 3, 2025, 16:23 ET
- Period: 2025-10-28
- Accession: 0001193125-25-262610
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070494/000119312525262610/acad-20251028.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070494/000119312525262610/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070494/000119312525262610/acad-20251028.htm

Filed Nov 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-262610. Last ingested by Listed: Nov 10, 2026, 16:33 ET. No prices; not investment advice.
